Publication | Closed Access

Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy

NanoparticlesNanomedicineOrganic/inorganic Hybrid NanocarriersMesoporous Silica NanoparticlesEngineeringNanomaterialsPolymer-drug ConjugateTherapeutic NanomaterialsNano-drug DeliveryColon CancerRadiation Oncology